INVACARE TAYLOR STREET

Manufacturer adverse-event records for INVACARE TAYLOR STREET come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2011–2026 · heavy-book · typical Death-code · injury-light

Injury-mix signature

INVACARE TAYLOR STREET is lighter on Injury codes

Injury-coded event_type share is 1.2% (injury-light tercile) beside 0.15% Death-coded (typical). Volume band: heavy.

What the Injury-mix reading shows for INVACARE TAYLOR STREET

The standout signal for INVACARE TAYLOR STREET is Injury-mix: 1.2% Injury-coded (injury-light) beside 0.15% Death-coded, on a heavy-book footprint.

As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair INVACARE TAYLOR STREET with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.

Reports span 20 device types, led in this extract by Malfunction at 25,160 (98.2% of event_type total). Peak single-year volume reaches 8,532 reports across 16 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

25,616
Total Reports
38
Event-type Death
304
Injury Reports
20
Device Types

Event Types

Malfunction 25,160 (98.2%)
Injury 304 (1.2%)
113 (0.4%)
Death 38 (0.1%)
Other 1 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Other 22,345 (86.8%)
2,997 (11.6%)
Hospitalization 123 (0.5%)
Required Intervention 91 (0.4%)
R 52 (0.2%)
O 46 (0.2%)
Death 38 (0.1%)
Congenital Anomaly 13 (0.1%)
S 9 (0.0%)
L 7 (0.0%)
Life Threatening 7 (0.0%)
H 6 (0.0%)
Disability 2 (0.0%)
D 1 (0.0%)

Yearly Trend

11
2011: 301
12
2012: 2,847
13
2013: 8,532
14
2014: 7,004
15
2015: 4,761
16
2016: 2,048
17
2017: 15
18
2018: 16
19
2019: 25
20
2020: 18
21
2021: 6
22
2022: 2
23
2023: 8
24
2024: 14
25
2025: 17
26
2026: 2